Walleye Capital LLC Biocryst Pharmaceuticals Inc Transaction History

Walleye Capital LLC

  • $54.3 Billion
  • Q2 2024

A detailed history of Walleye Capital LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Walleye Capital LLC holds 208,825 shares of BCRX stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
208,825
Previous 24,800 742.04%
Holding current value
$1.65 Million
Previous $125,000 932.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.13 - $6.79 $599,151 - $985,045
145,073 Added 227.56%
208,825 $1.29 Million
Q1 2024

May 15, 2024
SELL
$4.89 - $7.65 $3.18 Million - $4.98 Million
-650,706 Reduced 91.08%
63,752 $323,000
Q4 2023

Feb 14, 2024
BUY
$4.98 - $6.77 $18,958 - $25,773
3,807 Added 0.54%
714,458 $4.28 Million
Q3 2023

Nov 14, 2023
BUY
$6.71 - $7.92 $3.59 Million - $4.23 Million
534,472 Added 303.37%
710,651 $5.03 Million
Q2 2023

Aug 14, 2023
BUY
$6.96 - $8.81 $1.16 Million - $1.47 Million
166,635 Added 1745.97%
176,179 $1.24 Million
Q1 2023

May 15, 2023
SELL
$7.94 - $11.84 $4.73 Million - $7.06 Million
-595,989 Reduced 98.42%
9,544 $79,000
Q4 2022

Feb 14, 2023
BUY
$10.5 - $14.2 $3.82 Million - $5.17 Million
364,119 Added 150.83%
605,533 $6.95 Million
Q3 2022

Nov 14, 2022
BUY
$10.79 - $14.81 $1.96 Million - $2.69 Million
181,816 Added 305.07%
241,414 $3.04 Million
Q2 2022

Aug 08, 2022
SELL
$7.89 - $17.88 $970,225 - $2.2 Million
-122,969 Reduced 67.36%
59,598 $631,000
Q1 2022

May 16, 2022
BUY
$11.56 - $19.76 $2.11 Million - $3.61 Million
182,567 New
182,567 $2.97 Million
Q4 2021

Mar 03, 2022
SELL
$11.18 - $15.46 $459,844 - $635,885
-41,131 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$14.21 - $17.65 $386,128 - $479,603
27,173 Added 194.68%
41,131 $591,000
Q2 2021

Aug 16, 2021
BUY
$9.5 - $17.24 $132,601 - $240,635
13,958 New
13,958 $221,000
Q2 2020

Aug 14, 2020
SELL
$1.9 - $5.61 $297,363 - $878,004
-156,507 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$1.6 - $4.11 $85,051 - $218,475
53,157 Added 51.43%
156,507 $313,000
Q4 2019

Feb 14, 2020
BUY
$1.59 - $3.45 $164,326 - $356,557
103,350 New
103,350 $357,000

Others Institutions Holding BCRX

# of Institutions
257
Shares Held
173M
Call Options Held
397K
Put Options Held
444K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.47B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email